Composition for inhibiting melanin synthesis comprising Tuber melanosporum extract

A black truffle extract-based composition addresses the limitations of conventional skin whitening agents by providing effective melanin inhibition and stability, suitable for cosmetics, pharmaceuticals, and food products.

KR103046681B1Active Publication Date: 2026-11-11BIOSPECTRUM
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
KR1020240085413
Authority / Receiving Office
KR · KR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-06-28
Publication Date
2026-11-11
Estimated Expiration
2044-06-28

AI Technical Summary

Technical Problem

Conventional skin whitening agents like hydroquinone, ascorbic acid, kojic acid, and thiol compounds suffer from skin irritation, instability, odor issues, and formulation challenges, while natural herbal extracts lack identified active ingredients and stability, complicating their use in cosmetics.

Method used

A composition using black truffle extract, obtained through ultrasonic extraction and concentration, is formulated into cosmetic, pharmaceutical, and food products to inhibit melanin production effectively and safely.

Benefits of technology

The black truffle extract demonstrates superior melanin production inhibition with no skin irritation, ensuring product stability and efficacy in skin whitening and hyperpigmentation treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 112024070457812-PAT00001_ABST
    Figure 112024070457812-PAT00001_ABST
Patent Text Reader

Abstract

The present invention relates to a composition for inhibiting melanin production comprising black truffle extract as an active ingredient. The black truffle extract can be safely used without adverse effects on human skin, and also has an excellent effect in inhibiting pigmentation by inhibiting melanin production within cells. Therefore, a composition containing it as an active ingredient is highly effective for skin whitening and for preventing, improving, or treating hyperpigmentation.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] The present invention relates to a composition for inhibiting melanin production, and more specifically, to a composition for inhibiting melanin production comprising a black truffle extract that has excellent product stability, can be used safely without adverse effects on the skin, and has an excellent pigmentation inhibitory effect by inhibiting melanin production. Background Technology

[0002] Human skin color is determined by the concentration and distribution of melanin within the skin, and in addition to genetic factors, it is also influenced by environmental or physiological conditions such as solar ultraviolet radiation, fatigue, and stress. Melanin pigment, produced by melanocytes in the human skin, is a phenolic polymer consisting of a complex of black pigment and protein, playing a crucial role in blocking skin damage caused by ultraviolet radiation. The action of tyrosinase, present in melanocytes, is reported to be the most important factor in melanin biosynthesis. Tyrosinase plays a key role in the process of skin darkening by converting tyrosine, a type of amino acid, into DOPA and dopaquinone, which are intermediate products of melanin polymer formation. However, while the pathway by which melanin is produced is known, the specific mechanism by which tyrosinase induces melanin synthesis—the step preceding its action—has not yet been fully elucidated.

[0003] When melanin synthesis occurs excessively within the skin, it darkens the skin tone and causes melasma and freckles. Therefore, inhibiting the synthesis of melanin pigment within the skin can not only brighten the skin tone and achieve skin whitening, but also improve skin hyperpigmentation such as melasma and freckles caused by ultraviolet rays, hormones, and genetic factors.

[0004] Therefore, conventionally, substances possessing inhibitory activity against tyrosinase, such as hydroquinone, ascorbic acid, kojic acid, and glutathione, have been used to improve skin whitening or hyperpigmentation. However, while hydroquinone exhibits a desired whitening effect, it poses the problem of severe skin irritation, requiring its formulation amount to be limited to a very small quantity. Ascorbic acid is easily oxidized in aqueous solutions, leading to issues such as discoloration, changes in odor, and a failure to produce sustained effects in cosmetics containing it. Furthermore, kojic acid is unstable in solution, which complicates the cosmetic manufacturing process. Additionally, thiol compounds such as glutathione and cysteine ​​not only possess a characteristic unpleasant odor but also present problems with transdermal absorption; moreover, their glycosides and derivatives are highly polar, making them difficult to use as ingredients in cosmetic formulations. Accordingly, skin whitening compositions containing natural herbal extracts have recently been developed, but most of them are colored, posing problems in formulation, and since the active ingredients have not been identified, the same effect cannot be expected during product manufacturing.

[0005] Meanwhile, truffles are edible mushrooms belonging to the genus Tuber in the family Truffleaceae. Growing primarily underground in oak forests, they are one of the world's top three luxury ingredients. They differ in scientific name, appearance, aroma, and taste from Rhizopogoni rubescens, a mushroom of the family Rhizopogoniaceae that grows mainly in sandy pine forests in the Northern Hemisphere, including Korea and Japan. Depending on the species or habitat, truffles can be black, brown, or white, each exhibiting distinct differences in taste and aroma. Black truffles come in various varieties, including Tuber melanosporum, Burgundy truffle (Tuber uncinatum), and summer truffle (Tuber aestivum). The primary aromatic compound, 2,4-dithiapentein, is a type of thioether containing sulfur, resulting in an intense scent. Unlike ordinary mushrooms, black truffles grow near tree roots and are famous for their exceptional taste and strong, unique aroma. They are difficult to harvest because they cannot be artificially cultivated and are hard to find with the naked eye.

[0006] Black truffles are most well known for their anti-aging effects. For example, Korean Published Patent No. 10-2021-0027113 discloses that a fermented truffle extract activates the FOXO3 and SIRT1 genes, which are representative aging-related factors, thereby improving wrinkles and enhancing skin elasticity. Additionally, Korean Published Patent No. 10-2017-0029547 [discloses] truffles ( Tuber Mealnosporum A truffle aqueous extract obtained by aqueous extraction and enzymatic hydrolysis of the fruiting body of ) contains compounds with a molecular weight of less than 5 kDa and is disclosed to have reduced the levels of reactive oxygen species, which are a cause of aging in skin cells, and increased the ATP levels and viability of UV-treated fibroblasts.

[0007] Accordingly, while researching the efficacy of black truffles, the inventors newly discovered that black truffle extract has excellent whitening effects, high stability, and no skin side effects, and thus completed the present invention. Prior art literature

[0008] Republic of Korea Published Patent No. 10-2021-0027113 (Published March 10, 2021) Republic of Korea Published Patent No. 10-2017-0029547 (Published March 15, 2017) The problem to be solved

[0009] One objective of the present invention is to provide a composition for inhibiting melanin production comprising black truffle extract.

[0010] Another objective of the present invention is to provide a cosmetic, pharmaceutical, topical skin preparation, or food composition comprising the above-mentioned composition for inhibiting melanin production.

[0011] Another objective of the present invention is to provide a method for preventing, improving, or treating hyperpigmentation in an individual by administering the above-mentioned composition for inhibiting melanin production to the individual. means of solving the problem

[0012] In one embodiment, the present invention provides a composition for inhibiting melanin production comprising black truffle extract.

[0013] More specifically, the present invention provides a composition for inhibiting melanin production comprising a black truffle extract as an active ingredient, which has an excellent pigmentation inhibitory effect by inhibiting intracellular melanin production.

[0014] In the present invention, the term "extract" refers to a product such as a liquid component obtained by immersing a target substance in various solvents and then extracting and fractionating it for a certain period of time at room temperature or under heated conditions, or a solid component obtained by removing the solvent from said liquid component. Furthermore, in addition to said product, it may be comprehensively interpreted to include all diluted solutions of said product, concentrates thereof, modified products thereof, purified products, etc.

[0015] In the present invention, the black truffle is a truffle, tuberose ( Tuber It is a black mushroom of the genus ), and its types include Tuberculin melanosporum ( Tuber melanosporum ), Burgundy Truffle( Tuber uncinatum ), Summer Truffle( Tuber aestivum There are ) etc.

[0016] As a specific example, the black truffle mentioned above is Tuber Melanosporum ( Tuber melanosporum You can use ).

[0017] In the present invention, the black truffle extract can be prepared from the mycelium, fruiting body, or both the mycelium and fruiting body of the black truffle, preferably from the fruiting body, more preferably from the above-ground part of the fruiting body.

[0018] In the present invention, black truffle extract can be obtained by extraction with water or various organic solvents. At this time, the organic solvent used is not particularly limited thereto as long as it can obtain an extract having a melanin production inhibitory effect, but preferably it can be water, a polar solvent or a non-polar solvent, more preferably it can be water, a lower alcohol having 1 to 4 carbon atoms (ethanol, methanol, propanol or butanol, etc.), a mixed solvent thereof, etc., and preferably ethanol, more preferably 60 to 80% ethanol, even more preferably 65 to 75% ethanol, and even more preferably 70% ethanol.

[0019] Furthermore, the method for obtaining the above extract is not particularly limited to any method, as long as it yields an extract having a melanin production inhibitory effect. Extraction methods include cold maceration extraction, ultrasonic extraction, or reflux cooling extraction, and it is preferable to perform the extraction using the ultrasonic extraction method.

[0020] The above ultrasonic extraction is a method of extracting useful components from various natural materials at room temperature using physical force rather than chemical force by using a vibration element with a vibration frequency of more than 20,000 times per second. Unlike solvent extraction, vegetable oil extraction, or steam distillation extraction, it has the advantage of being able to extract active ingredients contained in natural materials at high concentrations at room temperature without destroying them.

[0021] As a specific example, the ultrasonic extraction can be performed on dried black truffle powder using a 60% to 80% ethanol solution at room temperature for 24 to 72 hours. Preferably, it is performed using a 65% to 75% ethanol solution at room temperature for 36 to 60 hours, and more preferably, using a 70% ethanol solution at room temperature for 48 hours. If the value falls outside the lower limit of the above values, the active ingredient of the present invention contained in the black truffle is not sufficiently extracted, and if the value exceeds the upper limit, there is no significant difference in the amount of active ingredient extracted, impurities other than the active ingredient are extracted, and the efficiency of the process decreases.

[0022] The black truffle extract obtained above may be concentrated under reduced pressure using a vacuum vacuum concentrator or a vacuum rotary evaporator, though not limited thereto. Additionally, after concentration under reduced pressure, it may be dried through freeze-drying, vacuum drying, vacuum drying, boiling drying, or spray drying, though not limited thereto.

[0023] In one specific embodiment, the melanin-inhibiting composition of the present invention may be a cosmetic composition for skin whitening.

[0024] In addition to black truffle extract as an active ingredient, the cosmetic composition of the present invention may further include ingredients typically added to cosmetic compositions, such as antioxidants, stabilizers, solubilizers, vitamins, pigments, and fragrances, as well as carriers.

[0025] In addition, the cosmetic composition may include, as needed, moisturizers, anti-inflammatory agents, antibacterial agents, antifungal agents, vitamins, sunscreens, antibiotics, perfumes, and dyes.

[0026] The cosmetic composition of the present invention may be prepared in any formulation conventionally manufactured in the art, for example, as a solution, emulsion, suspension, paste, cream, lotion, gel, powder, spray, surfactant-containing cleansing, oil, soap, liquid cleansing agent, bath additive, foundation, makeup base, essence, lotion, foam, pack, softening water, sunscreen cream or sun oil, but is not limited thereto. More specifically, it may be prepared in the form of a nourishing cream, astringent lotion, softening lotion, lotion, essence, nourishing gel, or massage cream.

[0027] In the case where the formulation of the present invention is a paste, cream, or gel, animal oil, vegetable oil, wax, paraffin, starch, tragacanth gum, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide may be used as a carrier component.

[0028] In the case where the formulation of the present invention is a powder or a spray, toss, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, it may additionally include a propellant such as chlorofluorohydrocarbon, propane / butane, or dimethyl ether.

[0029] When the formulation of the present invention is a solution or an emulsion, a solvent, a solubilizing agent, or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol, or fatty acid ester of sorbitan.

[0030] In the case where the formulation of the present invention is a suspension, liquid diluents such as water, ethanol, or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar, or tragacanth gum, etc. may be used as carrier components.

[0031] In the case where the formulation of the present invention is a surfactant-containing cleansing agent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester, etc. may be used as a carrier component.

[0032] The above carrier may be a non-naturally occurring carrier.

[0033] The content of black truffle extract included in the above cosmetic composition is not particularly limited thereto, but may be included in an amount of 0.0001 to 20 weight%, preferably 0.0001 to 15 weight%, more preferably 0.001 to 15 weight%, and even more preferably 0.001 to 10 weight% based on the total weight of the composition. If the content of black truffle extract in the above composition is less than 0.0001 weight%, there is a disadvantage that the efficacy is weak. In addition, if the content of black truffle extract exceeds 20 weight%, the increase in effect with increasing content is negligible, and a problem may arise in that the stability of the cosmetic formulation is not ensured.

[0034] In another specific embodiment, the melanin-inhibiting composition of the present invention may be a pharmaceutical composition for the prevention and treatment of hyperpigmentation.

[0035] The above hyperpigmentation is a condition in which pigment is deposited excessively more than normal skin color, resulting in a darker skin color; it is also called hyperpigmentation, and examples include melasma, freckles, melanosis, acanthosis nigricans, and erythrodermatitis, but are not necessarily limited to these.

[0036] The prevention and treatment of the above-mentioned hyperpigmentation may be used in this specification with the same meaning as skin whitening.

[0037] The "pharmaceutical composition" of the present invention refers to a composition prepared for the purpose of preventing or treating a disease, and may be formulated into various forms according to conventional methods. For example, it may be formulated into oral formulations such as powders, granules, tablets, capsules, suspensions, emulsions, and syrups, and may be formulated into external preparations, suppositories, and sterile injectable solutions. As one specific example, the pharmaceutical composition of the present invention may be used in an oral formulation by oral administration. As another specific example, the pharmaceutical composition of the present invention may be used by methods such as direct application or scattering to the skin.

[0038] In addition, depending on each formulation, it may be manufactured by further including pharmaceutically acceptable carriers, such as buffers, preservatives, analgesics, solubilizers, isotonic agents, stabilizers, bases, excipients, lubricants, etc., which are known in the art.

[0039] The pharmaceutical composition of the present invention may be administered in a pharmaceutically effective amount. The term "pharmaceutically effective amount" in the present invention refers to an amount sufficient to treat a disease with a reasonable benefit / risk ratio applicable to medical treatment and that does not cause adverse effects, and the effective dose level may be determined based on factors including the patient's health status, severity, drug activity, sensitivity to the drug, method of administration, time of administration, route of administration and elimination rate, duration of treatment, drugs used in combination or concurrently, and other factors well known in the medical field.

[0040] Accordingly, by administering the pharmaceutical composition of the present invention to an individual, the production of melanin in skin cells is inhibited and hyperpigmentation is reduced, thereby promoting skin whitening and adjusting the skin color to normal or near normal.

[0041] The term "individual" as used in the present invention may be a mammal, such as a rat, livestock, mouse, or human, and preferably a human. The pharmaceutical composition of the present invention may be formulated in various forms for administration to an individual, and a representative formulation for parenteral administration is an injectable formulation, preferably an isotonic aqueous solution or suspension. The injectable formulation may be prepared according to techniques known in the art using a suitable dispersant or wetting agent and a suspending agent. For example, each component may be dissolved in saline solution or a buffer solution to be formulated for injection. Additionally, formulations for oral administration include, for example, ingestible tablets, buccal tablets, troches, capsules, elixirs, suspensions, syrups, and wafers, and these formulations may contain, in addition to the active ingredient, a diluent (e.g., lactose, dextrose, sucrose, mannitol, sorbitol, cellulose and / or glycine) and a lubricant (e.g., silica, talc, stearic acid and its magnesium or calcium salts and / or polyethylene glycol). The tablets may contain binders such as magnesium aluminum silicate, starch paste, gelatin, tragacanth, methylcellulose, sodium carboxymethylcellulose and / or polyvinylpyrrolidine, and may additionally contain disintegrants such as starch, agar, alginic acid or its sodium salt, absorbents, coloring agents, flavoring agents and / or sweeteners. The formulations may be prepared by conventional mixing, granulation, or coating methods.

[0042] In addition, the pharmaceutical composition of the present invention may further include adjuvants such as preservatives, wettable agents, emulsification promoters, salts or buffers for osmotic pressure regulation, and other therapeutically useful substances, and may be formulated according to conventional methods.

[0043] The pharmaceutical composition according to the present invention may be administered via various routes including oral, transdermal, subcutaneous, intravenous, or intramuscular, and the dosage of the active ingredient may be appropriately selected according to various factors such as the route of administration, the patient's age, gender, body weight, and the severity of the patient. In addition, the composition of the present invention may be administered in combination with a known whitening agent that can enhance the desired effect.

[0044] The route of administration of the pharmaceutical composition according to the present invention may be administered to humans and animals orally or parenterally, such as intravenously, subcutaneously, intranasally, or intraperitoneally. Oral administration includes sublingual application. Parenteral administration includes injection methods such as subcutaneous injection, intramuscular injection, and intravenous injection, as well as drip methods.

[0045] The content of black truffle extract included in the above pharmaceutical composition is not particularly limited thereto, but may be included in an amount of 0.0001 to 20 weight%, preferably 0.0001 to 15 weight%, more preferably 0.001 to 15 weight%, and even more preferably 0.001 to 10 weight% based on the total weight of the composition. If the content of black truffle extract in the above composition is less than 0.0001 weight%, there is a disadvantage that the efficacy is weak. In addition, if the content of black truffle extract exceeds 20 weight%, the increase in effect with increasing content is negligible, and a problem may arise in that the stability of the pharmaceutical formulation is not ensured.

[0046] In another specific embodiment, the melanin-inhibiting composition of the present invention may be a topical skin composition for skin whitening.

[0047] The topical skin composition according to the present invention may be formulated containing a cosmetically or dermatologically acceptable medium or base. This may be provided in any formulation suitable for topical application, for example, in the form of a solution, gel, solid, paste anhydrous product, emulsion obtained by dispersing an oil phase in an aqueous phase, suspension, microemulsion, microcapsule, microgranule, or ionic (liposome) and non-ionic vesicular dispersants, or in the form of a cream, skin toner, lotion, powder, ointment, spray, pack, or concealer stick. It may also be used in the form of a foam or in the form of an aerosol composition further containing a compressed propellant. These compositions may be prepared according to conventional methods in the art.

[0048] In addition, the topical skin composition according to the present invention may contain adjuvants commonly used in the field of cosmetics or dermatology, such as fatty substances, organic solvents, solvents, thickeners, gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, metal ion chelating agents, chelating agents, preservatives, vitamins, blockers, humectants, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles, or any other ingredients commonly used in cosmetics. The adjuvants are introduced in amounts commonly used in the field of cosmetics or dermatology.

[0049] The content of black truffle extract included in the above-mentioned topical skin composition is not particularly limited thereto, but may be included in an amount of 0.0001 to 20 weight%, preferably 0.0001 to 15 weight%, more preferably 0.001 to 15 weight%, and even more preferably 0.001 to 10 weight% based on the total weight of the composition. If the content of black truffle extract in the above-mentioned composition is less than 0.0001 weight%, there is a disadvantage that the efficacy is weak. In addition, if the content of black truffle extract exceeds 20 weight%, the increase in effect with increasing content is negligible, and a problem may arise in that the stability of the formulation of the topical skin preparation is not ensured.

[0050] In another specific embodiment, the melanin-inhibiting composition of the present invention may be a food composition for skin whitening.

[0051] The food composition of the present invention may include all foods in the conventional sense and may be used interchangeably with terms known in the art, such as functional foods and health functional foods.

[0052] The term "functional food" in the present invention refers to a food manufactured and processed using raw materials or ingredients that have functional properties useful to the human body, and "functionality" means consuming for the purpose of obtaining useful effects for health purposes, such as regulating nutrients or physiological actions regarding the structure and function of the human body.

[0053] In addition, the term "health functional food" in the present invention refers to a food manufactured or processed by methods such as extraction, concentration, purification, or mixing, using a specific component as a raw material or a specific component contained in a food raw material for the purpose of health supplementation, and refers to a food designed and processed to sufficiently exert biological regulatory functions on the body, such as biological defense, regulation of biological rhythms, and prevention and recovery of disease, through the said component, and the composition for the health food can perform functions related to the prevention of disease and recovery of disease.

[0054] When the black truffle extract of the present invention is used as a food composition, it may include ingredients that are typically added during food manufacturing in addition to these ingredients. For example, it includes proteins, carbohydrates, fats, nutrients, seasonings, and flavoring agents. The carbohydrates mentioned above are monosaccharides of glucose and fructose sugars, disaccharides such as maltose, sucrose, and oligosaccharides, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. The flavoring agents may include natural flavoring agents (taumatin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.)) and synthetic flavoring agents (saccharin, aspartame, etc.).

[0055] There are no specific restrictions on the types of the above foods. Examples include meat, sausage, bread, chocolate, candies, snacks, confectionery, pizza, ramen, other noodles, chewing gum, dairy products including ice cream, various soups, beverages, tea, drinks, alcoholic beverages, and vitamin complexes, and include all health foods in the conventional sense.

[0056] When the food of the present invention is a beverage, it may contain various flavoring agents or natural carbohydrates as additional ingredients, as in conventional beverages. The above natural carbohydrates may include monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and natural sweeteners such as dextrin and cyclodextrin, or synthetic sweeteners such as saccharin and aspartame.

[0057] In addition to the ingredients described above, the above food may contain various nutritional supplements, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonating agents used in carbonated beverages, etc. Furthermore, the health food of the present invention may contain fruit pulp for the production of natural fruit juices, beverages, and vegetable beverages. These ingredients may be used independently or in combination.

[0058] The content of black truffle extract included in the above food composition is not particularly limited thereto, but may be included in an amount of 0.0001 to 100 weight%, preferably 0.0001 to 50 weight%, and more preferably 0.001 to 20 weight% based on the total weight of the composition. If the content of black truffle extract in the above composition is less than 0.0001 weight%, there is a disadvantage that the efficacy upon consumption of the food is weak. In addition, the content of black truffle extract may be included at 100 weight%, but it may be preferable to include it at less than 50 weight% considering the manufacturing cost.

[0059] In another aspect, the present invention provides a method for whitening the skin or preventing, improving, or treating hyperpigmentation by administering the above-mentioned composition for inhibiting melanin production to an individual for the purpose of skin whitening or prevention, improvement, or treatment of hyperpigmentation, thereby reducing the melanin concentration in the individual's skin.

[0060] The above-mentioned organism refers to mammals including humans, such as monkeys, cattle, horses, pigs, sheep, dogs, cats, rats, mice, chimpanzees, etc., for which the purpose can be achieved by administering the composition for inhibiting melanin production of the present invention.

[0061] The above administration means introducing a specific substance into an individual by any appropriate method, and the administration route of the composition of the present invention may be oral or parenteral through any general route as long as it can reach the target tissue. Additionally, the composition of the present invention may be administered by any device capable of delivering the active substance to a target, e.g., a cell.

[0062] A suitable dosage of the composition of the present invention may vary depending on the individual's condition and body weight, the severity of the disease, the form of the drug, and the time, but can be appropriately selected by a person skilled in the art. For example, the daily dosage of the composition is 1.0 ml to 3.0 ml for adults, and may be administered by application 1 to 5 times a day as needed.

[0063] Meanwhile, the black truffle extract of the present invention is a natural medicinal plant and showed no toxicity or irritation in tests conducted on the human body, so it can be safely used as an active ingredient in cosmetic compositions, pharmaceutical compositions, external skin preparation compositions, or food compositions. Effects of the invention

[0064] The black truffle extract according to the present invention has a significantly superior effect in inhibiting intracellular melanin production compared to vitamin C, and since it has no toxicity or irritation to the human body, it can be usefully used as an active ingredient in cosmetics, pharmaceuticals, topical skin preparations, or food for skin whitening and inhibition of hyperpigmentation. Brief explanation of the drawing

[0065] Figure 1 is a figure showing the inhibitory effect of black truffle extract on melanin production in mouse pigment cells (B16 melanoma). Figure 2 is a figure showing the inhibitory effect of black truffle extract on melanin production in human melanocytes. Specific details for implementing the invention

[0066] Hereinafter, the present invention will be described in detail with reference to examples and the like to aid in understanding the invention. However, the embodiments according to the present invention may be modified in various different forms, and the scope of the present invention should not be interpreted as being limited to the following embodiments. The embodiments of the present invention are provided to more completely explain the invention to those with average knowledge in the art.

[0067] Example 1: Preparation of Black Truffle Extract

[0068] Black truffles Tuber Melanosporum The above-ground fruiting body of Morello International was thoroughly washed to completely remove foreign substances and impurities, air-dried at 20°C to 35°C, and then ground to a particle size of 1 mm or less. Subsequently, the ground black truffle powder was immersed in a 70% ethanol solvent and subjected to ultrasonic extraction for 48 hours, after which the obtained extract was filtered using filter paper (Advantec, No. 2). The filtrate was concentrated under reduced pressure and then freeze-dried to produce the product.

[0069] Example 2: Measurement of the inhibitory effect of black truffle extract on melanin production in B16 melanoma cells

[0070] The inhibitory effect of black truffle extract on melanin production was measured using mouse pigment cells (B16 melanoma), and compared with the inhibitory effect of vitamin C, which is known to inhibit melanin production.

[0071] Specifically, murine melanoma (B16-F10) cells were placed in a 6-well plate containing DMEM medium with 10% FBS (fetal bovine serum) at a concentration of 1 × 10⁶ per well. 5 After vaccinating the dog, 5% CO2 and Cells were cultured at 37 ℃ for one day until they attached to the bottom. After culture, the medium was removed, and the cells were stimulated with 50 μM α-MSH, a melanogenesis stimulant, for one day. Subsequently, the samples were treated with medium diluted to an appropriate concentration, and 5% CO₂ 2, The cells were cultured at 37°C for 3 days. The concentration range of the black truffle extract was determined to be 1, 5, and 10 ppm, which are non-cytotoxic. Cells from which the medium had been removed were washed with PBS (phosphated buffer saline) and recovered by treating them with trypsin. The number of recovered cells was measured using a hematocytometer, and the cells were divided into equal numbers for each treatment group and placed into 2 mL tubes. The tubes were then centrifuged at 5,000 to 10,000 rpm for 10 minutes, and the supernatant was removed to obtain a pellet. This cell pellet was dried at 60°C, and then 100 µl of 1 M sodium hydroxide solution was added and dissolved in a 60°C incubator to obtain an intracellular melanin solution. The absorbance of this solution was measured at 490 nm using a microplate reader to determine the amount of melanin per unit of cell, and the melanin production inhibition rate was calculated based on the α-MSH group. The results are shown in Table 1 below.

[0072] Sample Treatment concentration (ppm) Melanin production inhibition rate (%) Vitamin C 1 0 5 0 10 2 Black truffle extract 1 4 5 53 10 60

[0073] As described in Table 1 above, black truffle extract showed a superior melanin production inhibition rate compared to vitamin C at the same treatment concentration in B16 melanoma cells.

[0074] Example 3: Measurement of the inhibitory effect of black truffle extract on melanin production in human melanocytes

[0075] The inhibitory effect of black truffle extract on melanin production was measured using human melanocytes, and compared with the inhibitory effect of vitamin C, which is known to inhibit melanin production.

[0076] Specifically, neonatal-derived human epidermal melanocytes purchased from Thermo Fisher were cultured in Medium 254 containing human melanocyte growth supplement also purchased from the same company. Human epidermal melanocytes were cultured in 6-well plates at a density of 1.5 × 10⁶ per well. 5 After inoculation, the cells were cultured for one day under 5% CO2 at 37°C until they adhered to the bottom. After culture, the medium was removed, and the cells were treated with medium diluted to an appropriate concentration of the sample. The cells were then cultured for 5 days under 5% CO2 at 37°C. The concentration range of the black truffle extract was determined to be 1, 5, and 10 ppm, which are non-cytotoxic. After treatment, the medium was removed, and the cells were washed with PBS (phosphated buffer saline) and treated with trypsin to recover them. The recovered cells were counted using a hematocytometer, and the cell counts were equalized for each treatment group before being divided into 2 mL tubes. The tubes were centrifuged at 5,000 to 10,000 rpm for 10 minutes, and the supernatant was removed to obtain a pellet. This cell pellet was dried at 60°C, and then 100 µl of 1M sodium hydroxide solution was added and dissolved in a 60°C incubator to obtain an intracellular melanin solution. The amount of melanin per unit of cell was determined by measuring the absorbance at 490 nm using a microplate reader with this liquid, and the melanin production inhibition rate was calculated based on the group that received no treatment, and the results are shown in Table 2 below.

[0077] Sample Treatment concentration (ppm) Melanin production inhibition rate (%) Vitamin C 1 0 5 1 10 5 Black truffle extract 1 18 5 26 10 49

[0078] As described in Table 2 above, black truffle extract showed a superior melanin production inhibition rate compared to vitamin C at the same treatment concentration in human melanocytes.

[0079] Example 4: Black Truffle Safety test of extract on human skin

[0080] 4-1. Preparation of topical skin preparations containing black truffle extract

[0081] In order to confirm whether the black truffle extract, which was found to have excellent whitening effects as described above, is safe for human skin, a topical skin preparation containing the black truffle extract was prepared, and a skin safety verification experiment was conducted.

[0082] Topical skin preparations containing black truffle extract were prepared with the ingredient content shown in Table 3 below. In Table 3 below, the control group is a topical skin preparation that does not contain a whitening agent, and the test group is a topical skin preparation containing black truffle extract.

[0083] To prepare a topical skin preparation, purified water, glycerin, and butylene glycol were mixed and dissolved at 70°C (aqueous phase), and the remaining components, excluding the three components and trimethanolamine, were dissolved at 70°C (oil phase). The oil phase was added to the aqueous phase and first emulsified by stirring with a homomixer (Tokushu Kika, Japan), and finally, trimethanolamine was added. After removing the bubbles formed in the mixture, the mixture was cooled to room temperature to prepare the topical skin preparation.

[0084] ingredient Content (%) control group Test group purified water 72 72 glycerin 8.0 8.0 Butylene glycol 4.0 4.0 Black truffle extract 0 1.0 Caprylic Capri Triglyceride 8.0 8.0 Squalan 5.0 5.0 Cetearyl glucurside 1.5 1.5 Sorbitan Stearate 0.4 0.4 cetearyl alcohol 1.0 1.0 Trimethanolamine 0.1 0.1 Total weight 100 100

[0085] 4-2. Primary Skin Irritation Test

[0086] Whether black truffle extract irritates the skin was measured by applying a 24-hour closed patch to the back of 30 healthy adults using each topical skin preparation prepared in Example 4-1 above.

[0087] The patching method utilized a chamber (IQ Ultimate™) from Chemotechnique MB Diagnostics AB. 20 μL of each of the above topical skin agents was placed in the chamber, and closed patches were applied for 24 hours. Skin reactions were observed 30 minutes and 24 hours after patch removal, and the presence and degree of skin irritation were visually evaluated according to evaluation criteria. After calculating the average skin reactivity based on the judgment criteria in Table 4 according to Frosch & Kligman (1979) and the CTFA guideline (2007), the skin irritation level of each topical skin agent was evaluated using the following experimental formula 1 based on the skin irritation index in Table 5, which was classified by applying the Draize method.

[0088] [Empirical Formula 1]

[0089] Average Skin Irritation Index Calculation Formula

[0090] ∑ [(Grade × Number of subjects who responded) / (4; Highest grade × Total number of subjects)] ÷ Number of evaluations

[0091] sign Grade Irritation assessment - 0 No response + 1 Weak but distinctly visible erythematous reaction ++ 2 Erythematous reaction showing distinct erythema accompanied by papules or edema +++ 3 Severe erythematous reaction accompanied by edema and papules ++++ 4 Severe erythematous reaction accompanied by edema and blisters

[0092] Skin irritation index Skin irritation level assessment 0.00-0.25 Non-irritating 0.26-1.00 Mild irritation 1.01-2.50 Moderate irritation 2.51-4.00 Strong irritation

[0093] test substance Number of subjects who showed a response Average response 30 minutes later 24 hours later 1 2 3 4 1 2 3 4 control group - - - - - - - - 0.00 Test group - - - - - - - - 0.00 Number of subjects 30 30 30 30 30 30 30 30

[0094] In Table 6 above, no irritation reaction was observed in either the control group or the test group. Since the average reactivity was calculated to be 0.00 according to the formula described above, the topical skin preparation containing black truffle extract (test group) was determined to be a non-irritating substance and safe for human skin, just like the control group topical skin preparation.

Claims

Claim 1 A cosmetic composition for skin whitening containing black truffle extract as an active ingredient. Claim 2 A cosmetic composition for skin whitening according to claim 1, characterized in that the cosmetic composition has a formulation selected from the group consisting of a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, a surfactant-containing cleansing product, an oil, a powder foundation, an emulsion foundation, a wax foundation, and a spray. Claim 3 A cosmetic composition for skin whitening according to claim 1, wherein the black truffle extract is included in an amount of 0.0001 to 20 weight% based on the total weight of the entire composition. Claim 4 A pharmaceutical composition for the prevention or treatment of hyperpigmentation comprising black truffle extract as an active ingredient. Claim 5 A skin whitening topical composition containing black truffle extract as an active ingredient. Claim 6 delete

Citation Information

Patent Citations

  • Cosmetic composition comprising tuber melanosporum

    KR1020080061080A

  • Composition containing complex extracts including Tuber magnatum mycelium, Morus bombycis, Agastache rugosa, Rubus hirsutus, and Zizyphus jujube with whitening or antioxidant activity

    KR1020170111769A